Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia and Specialty Care. We also market a portfolio of specialty and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. The share (STO:SOBI) is listed on Nadsaq Stockholm. More information is available at www.sobi.com.
- Company Name:Sobi - Swedish Orphan Biovitrum Ab (publ)
(View Trends)
-
Headquarters: (View Map)Solna, Sweden
-
Pharmaceuticals
-
1,000 - 5,000 employees
- 1297865 Global Rank
- 19674 United States
-
Direct58.74%
-
Search35.74%
-
Referrals3.30%
-
Social2.23%
-
Display0.00%
-
Mail0.00%
- United States 60.7%
- Wentworth Institute of Technology
- 0 SDKs
- 0 Total reviews
- App Url: https://itunes.apple.com/app/sobi-swedish-orphan-biovitrum-ab-publ-/id554996575
- App Support: http://www.haepatient.com/patient/
- Genre: Medical
- Bundle ID: com.Sobi.HAELP
- App Size: 5.67 M
- Version: 1.1
- Release Date: September 1st, 2012
- Update Date: September 8th, 2012
Description:
This app helps you manage your HAE attacks and also offers a series of tools for optimizing treatment and records key information that can be passed to your physician.
They are headquartered at Solna, Sweden, and have 3 advertising & marketing contacts listed on Kochava. Sobi - Swedish Orphan Biovitrum Ab (publ) works with Advertising technology companies such as DoubleClick.Net, JW Player Tracking, FLoC Opt-Out, FLoC.
